Cogent Biosciences Stock (NASDAQ: COGT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 411.00 / 1.24M |
Day Range | - - - |
52 Wk Range | 3.67 - 13.36 |
Market Cap | $973.15M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 9.81% |
Days to Cover | 4.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cogent Biosciences (NASDAQ:COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB) and 4D Molecular Therapeutics (NASDAQ:FDMT).
There is no analysis for Cogent Biosciences.
Cogent Biosciences has a consensus price target of $18.36.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $8.9 last updated Today at July 23, 2024 at 8:34 AM EDT.
There are no upcoming dividends for Cogent Biosciences.
Cogent Biosciences’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Cogent Biosciences.
Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.